Endpoints News
BioNTech’s cancer vaccine misses mark Read in browser
Endpoints News
Thank you for reading, Test Researcher!
basic
UPGRADE
M Tue W Th F
13 October, 2026
ENDPOINTS at #JPM27 - BIOPHARMA'S NEW BALANCE OF POWER
Biopharma's balance of power is shifting, and in January, Endpoints journalists will press the people at the center of it on who's rising, who's falling and where the industry may land by the end of the decade. Join us at #JPM27 for exclusive conversations and interviews you won't get anywhere else. Save $200 on your all-access pass with Early Bird, or join us virtually for free.
presented by Parexel
Greater em­pa­thy, greater ef­fi­cien­cy: How pa­tient-first clin­i­cal de­vel­op­ment ben­e­fits all of us
top stories
1.
in focus
Exclusive: Rudy Tanzi has long searched for ways to prevent Alzheimer's. He thinks he's getting close
2. BioNTech’s head and neck cancer vaccine misses first of two goals
3.
news briefing
Beam suggests it can correct mutation; Pfizer to collaborate with Enodia
4. Roche's seventh China deal this year is a $1.2B obesity pact with an RNAi biotech
5. Paragon spins out ninth biotech, sending cardiopulmonary drugs to Alaunos
6. After $10.9B exit to AbbVie, Apogee execs join Paragon to scale its R&D, company creation engine
7. Syndax's lung disease ambitions for Niktimvo end with a Phase 2 failure
more stories
• 
Karen Weintraub
.

For 40 years, Rudolph Tanzi has been on a quest to prevent Alzheimer’s. Now, the Mass General Brigham researcher thinks he’s getting close. But because a trial would take so long, the company he’s formed, Acta Pharmaceuticals, is also selling supplements, Ryan Cross reports.
.
Karen Weintraub
Deputy Editor, Endpoints News
Endpoints webinars
Nov 12
12:30 pm ET
From data to diagnostic: How AI is powering biomarker discovery
Guardant Health
Nov 03
11:30 am ET
Trust, not autonomy: Deploying agentic AI in GxP environments
Katalyze
Nov 04
11:00 am ET
Cutting through the noise: How biopharma is actually using AI to scale oncology research
Flatiron Health
Oct 13
11:00 am ET
Commercial excellence and AI - a ripple, wave or a tsunami
ZS
Oct 15
1:00 pm ET
Insights into Polycystic Kidney Disease: The Potential of Clinicogenomic Data
Natera
Oct 20
11:00 am ET
Intelligent oversight and orchestration: How mission control is redefining R&D decision-making
ZS
Oct 21
11:00 am ET
From prediction to decision: Digital twins and predictive modeling in clinical development
Flatiron
Oct 22
11:00 am ET
A new model for clinical research – Expanding community trial access
Parexel
Oct 28
10:30 am ET
The evolution of MRD: From molecular detection to clinical decisions
ABBOTT